African horse sickness in Thailand: Challenges of controlling an outbreak by vaccination

被引:29
作者
Castillo-Olivares, Javier [1 ,2 ]
机构
[1] Univ Cambridge, Dept Vet Med, Lab Viral Zoonot, Cambridge CB3 0ES, England
[2] Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England
基金
欧盟地平线“2020”;
关键词
VIRUS NEUTRALIZING ANTIBODIES; RECOMBINANT CANARYPOX VIRUS; PROTECTIVE EFFICACY; IMMUNOGENICITY; IMMUNIZATION; ERADICATION; PROTEINS; ASSAY; MICE; AHSV;
D O I
10.1111/evj.13353
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
引用
收藏
页码:9 / 14
页数:6
相关论文
共 31 条
[1]   Real-time fluorogenic reverse transcription polymerase chain reaction assay for detection of African horse sickness virus [J].
Aguero, Montserrat ;
Gomez-Tejedor, Concepcion ;
Angeles Cubillo, Maria ;
Rubio, Consuelo ;
Romero, Esther ;
Angel Jimenez-Clavero, Miguel .
JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, 2008, 20 (03) :325-328
[2]   A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model [J].
Aksular, Mine ;
Calvo-Pinilla, Eva ;
Marin-Lopez, Alejandro ;
Ortego, Javier ;
Chambers, Adam C. ;
King, Linda A. ;
Castillo-Olivares, Javier .
VACCINE, 2018, 36 (46) :7003-7010
[3]   Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge [J].
Alberca, Berta ;
Bachanek-Bankowska, Katarzyna ;
Cabana, Marta ;
Calvo-Pinilla, Eva ;
Viaplana, Elisenda ;
Frost, Lorraine ;
Gubbins, Simon ;
Urniza, Alicia ;
Mertens, Peter ;
Castillo-Olivares, Javier .
VACCINE, 2014, 32 (29) :3670-3674
[4]   The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host [J].
Calvo-Pinilla, Eva ;
Gubbins, Simon ;
Mertens, Peter ;
Ortego, Javier ;
Castillo-Olivares, Javier .
ANTIVIRAL RESEARCH, 2018, 154 :132-139
[5]   Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48 h before, or 48 h after challenge [J].
Calvo-Pinilla, Eva ;
de la Poza, Francisco ;
Gubbins, Simon ;
Clement Mertens, Peter Paul ;
Ortego, Javier ;
Castillo-Olivares, Javier .
ANTIVIRAL RESEARCH, 2015, 116 :27-33
[6]   Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation [J].
Calvo-Pinilla, Eva ;
de la Poza, Francisco ;
Gubbins, Simon ;
Mertens, Peter Paul Clement ;
Ortego, Javier ;
Castillo-Olivares, Javier .
VIRUS RESEARCH, 2014, 180 :23-30
[7]   A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR -/- Mouse Model [J].
Castillo-Olivares, Javier ;
Calvo-Pinilla, Eva ;
Casanova, Isabel ;
Bachanek-Bankowska, Katarzyna ;
Chiam, Rachael ;
Maan, Sushila ;
Maria Nieto, Jose ;
Ortego, Javier ;
Mertens, Peter Paul Clement .
PLOS ONE, 2011, 6 (01)
[8]   Induction of Antibody Responses to African Horse Sickness Virus (AHSV) in Ponies after Vaccination with Recombinant Modified Vaccinia Ankara (MVA) [J].
Chiam, Rachael ;
Sharp, Emma ;
Maan, Sushila ;
Rao, Shujing ;
Mertens, Peter ;
Blacklaws, Barbara ;
Davis-Poynter, Nick ;
Wood, James ;
Castillo-Olivares, Javier .
PLOS ONE, 2009, 4 (06)
[9]   African Horse Sickness: A Review of Current Understanding and Vaccine Development [J].
Dennis, Susan J. ;
Meyers, Ann E. ;
Hitzeroth, Inga I. ;
Rybicki, Edward P. .
VIRUSES-BASEL, 2019, 11 (09)
[10]   Immunogenicity of plant-produced African horse sickness virus-like particles: implications for a novel vaccine [J].
Dennis, Susan J. ;
Meyers, Ann E. ;
Guthrie, Alan J. ;
Hitzeroth, Inga I. ;
Rybicki, Edward P. .
PLANT BIOTECHNOLOGY JOURNAL, 2018, 16 (02) :442-450